CO
COG.LSE Cambridge Cognition Holdings Plc
- Market cap
- GBX 14.8M
- P/E
- -
- P/B
- 6.90x
- ROE
- -134.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is COG.LSE undervalued?
Graham numberThe Graham number of Cambridge Cognition Holdings Plc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cambridge Cognition Holdings Plc fundamental analysis
No fundamental analysis for Cambridge Cognition Holdings Plc yet.
Cambridge Cognition Holdings Plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers sensitive, precise and objective measures of cognitive function, correlated to neural networks; voice analysis, an automated speech recognition tool for monitoring neurological and psychiatric disorders; and high frequency testing that detects fluctuations in brain health w…
Full company profileCambridge Cognition Holdings Plc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cambridge Cognition Holdings Plc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 6.88M | 6.73M | 6.13M | 5.04M | 6.74M | 10.1M | 12.6M | 13.5M | 10.3M | 9.40M | 20.2M |
| Gross Profit | 5.89M | 6.11M | 5.23M | 3.89M | 5.42M | 8.08M | 9.32M | 10.8M | 8.39M | 7.01M | 15.1M |
| Operating Income | 116K | -284K | -1.49M | -3.05M | -546K | 264K | -936K | -3.31M | -1.17M | -1.55M | -2.56M |
| EBITDA | 184K | -207K | -1.43M | -2.95M | -502K | 412K | -514K | -2.62M | -542K | -960K | -1.48M |
| Net Income | 272K | -257K | -1.44M | -2.90M | -438K | 450K | -409K | -3.51M | -1.79M | -1.68M | -2.94M |
| EPS | 0.01 | -0.01 | -0.07 | -0.12 | -0.01 | 0.01 | -0.01 | -0.10 | -0.05 | -0.04 | -0.06 |
| Balance Sheet | |||||||||||
| Total Assets | 5.07M | 4.58M | 3.45M | 3.16M | 6.26M | 12.5M | 15.1M | 14.2M | 13.0M | 11.3M | 11.3M |
| Total Liabilities | 2.21M | 1.55M | 3.98M | 4.10M | 6.21M | 11.9M | 15.0M | 12.9M | 9.67M | 8.29M | 9.12M |
| Shareholders' Equity | 2.91M | 3.03M | -526K | -944K | 57.0K | 632K | 95.0K | 1.28M | 3.36M | 2.99M | 2.19M |
| Cash & Short-term Investments | 2.38M | 1.86M | 1.11M | 901K | 3.05M | 6.81M | 8.32M | 3.23M | 1.30M | 1.13M | 582K |
| Total Debt | - | - | - | 92.0K | 98.0K | 18.0K | 18.0K | 2.56M | 1.91M | 873K | 239K |
| Cash Flow | |||||||||||
| Operating Cash Flow | 473K | -624K | -644K | -2.32M | 1.01M | 3.93M | 1.68M | -4.97M | -3.09M | -232K | 784K |
| Capital Expenditure | 44.0K | 48.0K | 25.0K | 55.0K | 42.0K | 56.0K | 189K | 33.0K | 3.00K | 30.0K | 76.0K |
| Free Cash Flow | 429K | -672K | -669K | -2.37M | 972K | 3.88M | 1.49M | -5.00M | -3.09M | -262K | 708K |
| Ratios | |||||||||||
| ROE | 9.3% | -8.5% | - | - | -768.4% | 71.2% | -430.5% | -273.4% | -53.1% | -55.9% | -134.4% |
| ROA | 5.4% | -5.6% | -41.8% | -91.8% | -7.0% | 3.6% | -2.7% | -24.7% | -13.7% | -14.8% | -26.0% |
| Net Profit Margin | 4.0% | -3.8% | -23.5% | -57.5% | -6.5% | 4.5% | -3.2% | -26.0% | -17.3% | -17.8% | -14.6% |
| Debt to Equity | - | - | - | - | 1.72x | 0.03x | 0.19x | 2.00x | 0.57x | 0.29x | 0.11x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cambridge Cognition Holdings Plc dividends
Cambridge Cognition Holdings Plc has not paid dividends in the last 9 fiscal years.
Who owns Cambridge Cognition Holdings Plc
- Insiders 32.70%
- Institutions 45.17%
- Public & others 22.13%
- Shares outstanding 54.0M
- Free float 29.2M
Cambridge Cognition Holdings Plc company profile
- Company name
- Cambridge Cognition Holdings Plc
- Ticker
- COG.LSE
- ISIN
- GB00B8DV9647
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 74
- Fiscal year end
- December
- Address
- Tunbridge Court, Cambridge, United Kingdom, CB25 9TU
- Phone
- 44 1223 810 700
- Website
- cambridgecognition.com
About Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers sensitive, precise and objective measures of cognitive function, correlated to neural networks; voice analysis, an automated speech recognition tool for monitoring neurological and psychiatric disorders; and high frequency testing that detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), a digital bespoke questionnaires that collects data within tight deadlines; and data quality management. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.
Cambridge Cognition Holdings Plc management
9- Mr. Robert BakerCEO, Joint MD & Senior Executive Director · born 1987
- Mr. James Ronald OpenshawCFO, Head of Corporate Development & Director · born 1967
- Mr. John HammondCo-Founder
- Ms. Francesca Cormack Ph.D.Chief Scientist & Member of Scientific Advisory Board
- Mr. Simon MerrittMarketing and Communications Director
- Mr. Nick TaptiklisHead of R&D
- Simon McKeatingCompany Secretary
- Prof. Trevor Robbins CBE, FBPsS, FMedSci, FRS, Ph.D.Senior Consultant
- Prof. Barbara Sahakian FBPsS, FMedSciSenior Consultant